SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (101)5/28/2001 2:06:54 PM
From: scaram(o)uche  Respond to of 598
 
thank you!! (eom)



To: tuck who wrote (101)5/28/2001 2:21:37 PM
From: Miljenko Zuanic  Respond to of 598
 
Tuck,

TLRK cancer candidates are not from GPCR programs. Also, every pharma and many bios are going after new tubulin binding anti-cancer candidates. Very heavy competition going forward.

BTW, I like more TELK compound, based on initial PI/Ib data.

Miljenko
[eom]